76. Cancer Cell. 2018 Jun 11;33(6):1094-1110.e8. doi: 10.1016/j.ccell.2018.04.010.Epub 2018 May 24.Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoralResponse to Taxanes in Breast Cancer Cells.Cánovas B(1), Igea A(1), Sartori AA(2), Gomis RR(3), Paull TT(4), Isoda M(1),Pérez-Montoyo H(5), Serra V(6), González-Suárez E(5), Stracker TH(1), NebredaAR(7).Author information: (1)Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona 08028, Spain.(2)University of Zurich, Institute of Molecular Cancer Research, Zurich 8057,Switzerland.(3)Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona 08028, Spain; ICREA, Pg. Lluís Companys 23,Barcelona 08010, Spain; Universitat de Barcelona and CIBERONC, Barcelona, Spain.(4)Howard Hughes Medical Institute, University of Texas at Austin, Austin, TX78712, USA.(5)Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical ResearchInstitute (IDIBELL), Barcelona 08908, Spain.(6)Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.(7)Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology, Barcelona 08028, Spain; ICREA, Pg. Lluís Companys 23,Barcelona 08010, Spain. Electronic address: angel.nebreda@irbbarcelona.org.Breast cancer is the second leading cause of cancer-related death among women.Here we report a role for the protein kinase p38α in coordinating the DNA damage response and limiting chromosome instability during breast tumor progression, andidentify the DNA repair regulator CtIP as a p38α substrate. Accordingly,decreased p38α signaling results in impaired ATR activation and homologousrecombination repair, with concomitant increases in replication stress, DNAdamage, and chromosome instability, leading to cancer cell death and tumorregression. Moreover, we show that pharmacological inhibition of p38α potentiatesthe effects of taxanes by boosting chromosome instability in murine models andpatient-derived xenografts, suggesting the potential interest of combining p38αinhibitors with chemotherapeutic drugs that induce chromosome instability.Copyright © 2018 Elsevier Inc. All rights reserved.DOI: 10.1016/j.ccell.2018.04.010 PMID: 29805078 